14.61USD+2.71%Mkt Cap: 26.00M USDP/E: 132.82Last update: 2026-06-01
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral sma…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap26.00M USD
Enterprise Value15.00M USD
Revenue (TTM)12.88M USD
Gross Profit0 USD
Net Income (TTM)-17.31M USD
Revenue/Share6.277 USD
Last Price14.61 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6960775020
Valuation
P/E (Trailing)132.82
P/E (Forward)-5.77
PEG1.62
EV/EBITDA-1.71
EV/Revenue1.16
P/S1.94
P/B2.15
EPS (TTM)0.11
EPS (Forward)-2.43
52W Range
4.50038% of range31.00
52W High31.00 USD
52W Low4.500 USD
Profitability
Gross Margin4.28%
Oper. Margin-40.33%
EBITDA Margin-67.95%
Profit Margin-48.50%
ROE362.30%
ROA-529.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.31M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-9.87M USD
Net Debt/EBITDA1.13
Balance Sheet
Debt/Equity-0.03
Current Ratio5.04
Quick Ratio4.86
Book Value/Sh6.525 USD
Cash/Share5.720 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateAug 12, 2025
Analyst Consensus
Rating—
Target (Mean)53.50 USD
Target Range47.50 USD – 60.00 USD
# Analysts3
Ownership
Shares Out.1.78M
Float1.38M
Insiders1.08%
Institutions55.10%
Short Interest
Short Ratio10.0d
Short % Float8.82%
Short % Out.8.79%
Shares Short156.33K
Short (prev mo.)158.14K
Technical
SMA 5018.89 (-22.7%)
SMA 20015.26 (-4.3%)
Beta-0.09
S&P 52W Chg27.94%
Avg Vol (30d)14.56K
Avg Vol (10d)16.48K
Technical Indicators
RSI (14)33.0
MACD-1.5496
MACD Signal-1.4012
MACD Hist.-0.1484
BB Upper21.63 USD
BB Middle16.66 USD
BB Lower11.68 USD
BB Width59.72%
ATR (14)1.206 USD
Vol Ratio (20d)0.42x